State Street Portfolio holdings
State Street is a bank holding company, with roots going back to Union Bank, chartered in 1792, that both manages investments and holds securities for other investors. The company takes its name from State Street in Boston, and in 1924 it began safekeeping the holdings of the country's first mutual fund, the Massachusetts Investors Trust. In 1993 it created the SPDR S&P 500 Trust, the first exchange-traded fund. State Street formed its asset management arm, State Street Global Advisors, in 1994, and in 1999 exited retail and commercial banking by selling those businesses to Citizens Financial Group. Its asset management division serves corporations, mutual funds, insurance companies and other institutional investors, running both index-tracking and actively managed strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.28B |
| 2 |
Apple
AAPL
|
+$2.37B |
| 3 |
Microsoft
MSFT
|
+$2.34B |
| 4 |
Vivmark Residential
VMRK
|
+$1.63B |
| 5 |
Broadcom
AVGO
|
+$1.56B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Electronic Arts
EA
|
+$2.88B |
| 2 |
AvalonBay Communities
AVB
|
+$1.73B |
| 3 |
Marathon Petroleum
MPC
|
+$668M |
| 4 |
Phillips 66
PSX
|
+$643M |
| 5 |
Valero Energy
VLO
|
+$566M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.16% |
| 2 | Financials | 11.79% |
| 3 | Healthcare | 10.03% |
| 4 | Industrials | 9.3% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2351
Aquestive Therapeutics
AQST
$491M
| $16.1M | ﹤0.01% |
3,481,391
+553,371
| +19% | +$2.46M |
2020 Q2
25 quarters
|
|
2352
LSI Industries
LYTS
$577M
| $16.1M | ﹤0.01% |
776,112
-3,694
| -0.5% | -$82.9K |
2013 Q2
53 quarters
|
|
2353
INNIO N.V.
INIO
$10.9B
| $16.1M | ﹤0.01% |
+887,823
| New | +$22.1M |
2026 Q3
0 quarters
|
|
2354
Arvinas
ARVN
$447M
| $16.1M | ﹤0.01% |
2,078,905
-117,967
| -5% | -$1.01M |
2018 Q4
31 quarters
|
|
2355
Bioventus
BVS
$730M
| $16M | ﹤0.01% |
1,171,999
+67,121
| +6% | +$884K |
2021 Q1
22 quarters
|
|
2356
Grid Dynamics Holdings
GDYN
$1.06B
| $16M | ﹤0.01% |
2,027,184
+8,191
| +0.4% | +$58.8K |
2020 Q2
25 quarters
|
|
2357
PubMatic
PUBM
$945M
| $15.9M | ﹤0.01% |
848,987
-5,160
| -0.6% | -$80.2K |
2021 Q2
21 quarters
|
|
2358
ARS Pharmaceuticals
SPRY
$391M
| $15.9M | ﹤0.01% |
3,688,580
-42,043
| -1% | -$246K |
2021 Q1
22 quarters
|
|
2359
Global Ship Lease
GSL
$1.55B
| $15.9M | ﹤0.01% |
359,909
+7,237
| +2% | +$313K |
2022 Q4
15 quarters
|
|
2360
Fervo Energy
FRVO
$3.4B
| $15.9M | ﹤0.01% |
1,167,208
+824,140
| +240% | +$16.7M |
2026 Q2
1 quarter
|
|
2361
Northrim BanCorp
NRIM
$533M
| $15.8M | ﹤0.01% |
652,410
-16,491
| -2% | -$435K |
2016 Q2
41 quarters
|
|
2362
Avalyn Pharma
AVLN
$1.34B
| $15.8M | ﹤0.01% |
554,004
+235,009
| +74% | +$7.58M |
2026 Q2
1 quarter
|
|
2363
MeiraGTx Holdings
MGTX
$882M
| $15.7M | ﹤0.01% |
1,425,600
+32,378
| +2% | +$420K |
2018 Q4
31 quarters
|
|
2364
Acacia Research
ACTG
$406M
| $15.6M | ﹤0.01% |
3,620,979
+454,262
| +14% | +$2.05M |
2013 Q2
53 quarters
|
|
2365
Burford Capital
BUR
$793M
| $15.6M | ﹤0.01% |
3,969,594
+191,417
| +5% | +$803K |
2024 Q2
9 quarters
|
|
2366
SOLV Energy Inc
MWH
$5.63B
| $15.5M | ﹤0.01% |
646,966
+213,091
| +49% | +$5.89M |
2026 Q1
2 quarters
|
|
2367
Ares Management Corp 6.75% Series B Preferred Stock
ARES.PRB
$1.29B
| $15.5M | ﹤0.01% |
407,888
-44,000
| -10% | -$1.85M |
2024 Q4
7 quarters
|
|
2368
Sprout Social
SPT
$685M
| $15.5M | ﹤0.01% |
1,586,337
-52,373
| -3% | -$501K |
2020 Q1
26 quarters
|
|
2369
PureCycle Technologies
PCT
$344M
| $15.5M | ﹤0.01% |
3,512,480
+180,806
| +5% | +$1.16M |
2021 Q2
21 quarters
|
|
2370
Thomson Reuters
TRI
$47.4B
| $15.5M | ﹤0.01% |
158,971
+4,530
| +3% | +$448K |
2013 Q2
53 quarters
|
|
2371
Cabaletta Bio
CABA
$276M
| $15.5M | ﹤0.01% |
8,053,077
+213,772
| +3% | +$602K |
2019 Q4
27 quarters
|
|
2372
Ovid Therapeutics
OVID
$479M
| $15.4M | ﹤0.01% |
6,203,161
-1,697,604
| -21% | -$4.44M |
2020 Q2
25 quarters
|
|
2373
Prothena Corp
PRTA
$419M
| $15.4M | ﹤0.01% |
1,841,677
-551,747
| -23% | -$4.93M |
2013 Q2
53 quarters
|
|
2374
BioNTech
BNTX
$21.2B
| $15.4M | ﹤0.01% |
156,827
-6,710
| -4% | -$651K |
2020 Q4
23 quarters
|
|
2375
Embraer S.A. ADS
EMBJ
$14B
| $15.4M | ﹤0.01% |
203,646
+9,412
| +5% | +$673K |
2013 Q2
53 quarters
|
|
Similar funds
State Street's Q3 2026 Portfolio in Review
As of Q3 2026, State Street held 4,412 positions worth $3.44T, up 1.5% from $3.38T the previous quarter. Its ten largest holdings account for 32% of the portfolio.
State Street's Q3 2026 filing shows 131 new, 2,095 increased, 1,596 reduced and 103 closed positions. Its largest new stake was Mobility Global Inc: 10,220,400 shares worth $175M. The largest sale was Electronic Arts, an estimated $2.88B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.
- State Street's largest Q3 2026 buy was Mobility Global Inc: 10,220,400 shares worth $175M.
- State Street added most to NVIDIA in Q3 2026, an estimated $3.28B increase.
- State Street's biggest Q3 2026 reduction was Marathon Petroleum, cutting an estimated $668M.
- State Street fully exited Electronic Arts in Q3 2026, selling an estimated $2.88B.
- State Street's ten largest holdings make up 32% of its $3.44T portfolio in Q3 2026.
- State Street opened 131 new positions and closed 103 in Q3 2026.
- State Street's portfolio value rose 1.5% quarter-over-quarter to $3.44T.
Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.